biopharmaceutics
Imagine you have the right drug in a pill, yet the patient still gets little benefit. The active molecule is correct, but the way it was packaged into the tablet decides how much actually dissolves, gets absorbed, and reaches the bloodstream. Biopharmaceutics is the science of exactly that hand-off — how the physical and chemical properties of a dosage form shape what the body finally receives.
More formally, biopharmaceutics studies the relationship between a drug product's physicochemical properties (particle size, crystal form, solubility, the choice of excipients and dosage form) and the rate and extent to which the drug is absorbed. It sits at the bridge between formulation science upstream and pharmacokinetics downstream, asking how a given formulation releases its drug so the body can take it up.
It is distinct from pharmacokinetics, which describes what the body does to a drug once it is in (absorption, distribution, metabolism, excretion). Biopharmaceutics focuses on the input side: how the product itself, before and during release, governs the amount and speed of drug entering the system. The two are tightly linked, but biopharmaceutics is where formulation choices meet biology.
Micronizing a poorly soluble drug like griseofulvin to a finer particle size increases its dissolution surface and markedly improves the amount absorbed — a classic biopharmaceutics result.
Particle size, a formulation choice, directly changes how much drug the body receives.
Two products with the same dose of the same drug can behave very differently in the body if their formulations differ — this is precisely why biopharmaceutics matters for generic approvals.